FDA Investigator Alan L Truong

Alan L Truong has conducted inspections on 43 sites in 6 countries as of 21 Mar 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
43
Last Inspection Date:
21 Mar 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, India, Mexico, Canada, Italy, Sweden
FDA Investigators that have inspected at least one site in common with Alan L Truong:
Alan E Mehl, Alan P Kurtzberg, Alexandria L Capuano, Alice S Tsao, Ana P Pineda Zavaleta, Anderson, Andrew A Hoopes, Andrew J Barrowcliff, Andrey Sarafanov, PhD, Ann Marie Montemurro, Ann Marie Schofield, Anthony F Lorenzo, Anthony R Bucks, Arie C Menachem, Arsen Karapetyan, Ashley A Mutawakkil, Babajide Michael Osunsanmi, Bei Y He, Binh T Nguyen, Brandy N Lepage, Brentley S Collins, Brett R Havranek, Brian P Putz, Brittany D Terhar, Bruce D Meade, Bryan A Galvez, Bryce A Hammer, Burnell M Henry, Carl A Huffman, III, Carla J Lundi, Carolina D Vasquez, Caryn M Mcnab, Cathleen A Carr Sharpe, CDR Donald Ertel, Charles L Zhou, Charles Yuanchia Kuo, PhD, Chilton L Ng, Chris A Sack, Christian D Lynch (CDL), Christine A Harman, PhD, Claudia Mperez Kasmarski, Cody D Rickman, Comyar Shoghi, Constantin Y Philopoulos, Cristina Ausin Moreno, PhD, Cynthia Jim, CSO, Cynthia L Kelley, Cynthia M Goudeau, Damaris Y Hernandez, Danial S Hutchison, Darren S Brown, David E Bailey, David G Whitman, David J Eide, David M Beltran, Davis, Deborah A Greco, Deborah M Trout, Diane L Raccasi, Diane R Weidley, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Donald L Myers, Dr. Jason R Caballero, Dr. Zhihao Qiu (Peter), PhD, Eboni S Funderburk, Edwin Jao, Eileen A Liu, Emilie E Kahn, Eric M Mueller, PharmD, Eric M Padgett, Esteban Beltran, Esther C Broner, PhD, Felix Maldonado, Gam S Zamil, Gene D Arcy, Glen C Lawrence, Gretchen Lf Trendel, Gwyn G Dickinson, Hector A Carrero, Heidy C Perales, Helen Y Saccone, Heriberto Negron Rivera, Holly Brevig, Hyung Yul Lee, Ivis L Negron, J Michael Cannon, PhD, Jacob G Lutz, Jacqueline Mdiaz Albertini, James A Lane, James B Arnett, James I Giefer, James R Fleckenstein, Janet B Abt, Jazmine M Welcher, Jazmine N Still, Jean Lhu Primmer, Jeffrey D Meng, Jeffrey M Watson, Jeffrey P Raimondi, Jennifer L Bridgewater, Jennifer L Reed, Jennifer M Gogley, Jessica L Pressley, Jie He, Jill J Tillman, Joan A Loreng, Joan Johnson, Joan M Cantellops Figueroa, Jocelyn E Massey, John A Gonzalez, Jolanna A Norton, Jon P Antoniou, Jose A Lopez, Jose Acruz Gonzalez, Joseph A Piechocki, Joseph R Lambert, Joslyn K Brunelle, PhD, Juanita Banuelos, Judy C Nepsa, Julie D Bringger, Karen L Kosar, Katherine E Jacobitz, Katherine Szestypalow, Kelley, Kellia N Hicks, Kelly K Nachtigal, Kelvin X Sanders, Ken L Bowers, Kenneth S Boehnen, Kevin D Kallander, Kham Phommachanh, Kimberly M Lichter, Kristin M Abaonza, Lance Mde Souza, MBA, Lanita F Kelley, Laura Fontan, MS, LCDR Debra Emerson, LCDR Sean Byrd, Leonard H Lavi, Lewis K Antwi, Liatte Kreuger, PharmD, Lillian S Wu, Liming Zhang, Linda Thai, Lisa L Flores, Lisa P Oakes, Lisa R Hilliar, Lisa Shin, Logan T Williams, Maida Henesian (NMI), Marcus F Yambot, Margaret A Smithers, Maria Cruz Fisher, Maria Estrella, Marion D Wimberly, Jr, Marlene G Swider, Marsha W Major, Marvin D Jones, Matthew M Schuckmann, Matthew R Sleeter, Maxyne T Lam, Megan T Ziegler, Meisha R Sampson, Meisha Waters, Melanie M Walker, Melissa D Ray, Michael C Kennedy, PhD, Michael C Zubelewicz, Michael D Garcia, Michael J Vardon, Michael L Casner, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Mikhail V Ovanesov, PhD, Mindy M Chou, Monica M Mcclure, Mra M Barbosar, Muna Algharibeh, Myra K Casey, Nadeem I Chaudhry, Nancy G Schmidt, Nancy Kirschbaum, PhD, Nayan J Patel, Neal L Adams, Nerizza B Guerin, Nicholas L Hunt, Nicholas L Paulin, Nicole E Knowlton, Noreen Muñiz, Olga Simakova, PhD, Omotunde O Osunsanmi, Ou Ma, Pankaj H Amin, Parul M Patel, Patsy J Domingo, Paula A Trost, Prabhu P Raju, Rabia Ballica, PhD, Rafael Nevarez Nieves, Rafeeq A Habeeb, Ralph H Vocque, Randa Melhem, PhD, Rebecca E Dombrowski, Rebecca K Olin, Richard L Rutherford, Richard Ledwidge (nmi), PhD, Richmond K Yip, Rita K Kabaso, Robert Barbosa, Robert J Ham, Robert M Barbosa, Robin K Reel, Rose Ashley, Saied A Asbagh, Sandra A Boyd, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah A Hassas, Sarah E Rhoades, Sargum C Sood, Scott A Golladay, Scott N Lim, Scott R Nichols, PhD, Scott T Ballard, Sean P Desbrow, Sergio Chavez (NMI), Shafiq S Ahadi, Shirley J Berryman, Sidney B Priesmeyer, Simone E Pitts, Sneha S Patel, Sonia R Peterson, Sonya L Karsik, RAC, Sparky L Bartee, Steven C Derrick, Steven D Kehoe, Steven P Donald, Sumit Sen, Susan F Laska, MS, Susan M Jackson, Susanna E Ford, Taichun Qin, PhD, Tamala P Magee, Tamara J Umscheid, Tara L Breckenridge, Tara L Greene, Tara L King, Thao T Kwan, Thomas J Arista, Thomas W Gordon, Timothy J Schmidt, Tracey T Duong, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vaishali J Patel, Veronica Fuentes, MS, Victoria A Wagoner, Virgilio F Pacio, CSO, Viviana Matta, Walden H Lee, Walsworth, Warren J Lopicka, Wayne E Seifert, Wendy G Tan, PhD, William D Tingley, Yanming An, PhD, Youkeun Kim, Yuan Chia Kuo, Yumi J Hiramine, Yvins Dezan, Zachary A Bogorad, Ze Peng, Zhong Li, PhD, Zi Qiang Gu

Alan L Truong's Documents

Publish Date Document Type Title
August, 2021 FDA 483 ACCU BIO-CHEM LABS - Form 483, 2021-08-31
November, 2018 FDA 483 Kadesh International - Form 483, 2018-11-07
September, 2021 FDA 483 Best Formulations Inc. - Form 483, 2021-09-30
October, 2019 FDA 483 Honest Globe, Inc. - Form 483, 2019-10-08
November, 2018 FDA 483 Fill it Pack It Inc - Form 483, 2018-11-05
September, 2021 EIR Best Formulations Inc. - EIR, 2021-09-30
September, 2020 FDA 483 Manna Omni International, Inc. - Form 483, 2020-09-24
August, 2019 FDA 483 TriRx Shawnee LLC - Form 483, 2019-08-01
April, 2021 FDA 483 Clinical Resolution Laboratory, Inc. - Form 483, 2021-04-27
June, 2022 FDA 483 TriReme Medical, LLC. - Form 483, 2022-06-17
January, 2020 FDA 483 Preferred Pharmaceuticals Inc. - Form 483, 2020-01-14
September, 2019 FDA 483 Private Label Partners, Inc. - Form 483, 2019-09-13
July, 2021 FDA 483 NuSil Technology LLC - Form 483, 2021-07-16
August, 2022 FDA 483 COSMETIC LAB INC. - Form 483, 2022-08-03
February, 2024 FDA 483 Grand River Aseptic Manufacturing Inc. - Form 483, 2024-02-21
November, 2023 FDA 483 Catalent Indiana, LLC - Form 483, 2023-11-15
December, 2022 EIR Interquim, S.A. de C.V. - EIR, 2022-12-16
December, 2022 FDA 483 Bayer de Mexico, S.A. de C.V. - Form 483, 2022-12-09
March, 2023 FDA 483 SHILPA MEDICARE LIMITED - Form 483, 2023-03-10
April, 2022 FDA 483 Westwood Laboratories, LLC. - Form 483, 2022-04-05
August, 2019 EIR TriRx Shawnee LLC - EIR, 2019-08-01
March, 2023 FDA 483 InterMed Laboratories Private Limited - Form 483, 2023-03-17
December, 2023 FDA 483 Emergent Biodefense Operations Lansing LLC - Form 483, 2023-12-13
June, 2019 FDA 483 Regenesis Pharmaceutical Inc. - Form 483, 2019-06-18
April, 2019 FDA 483 LIFETECH RESOURCES LLC - Form 483, 2019-04-05
September, 2022 FDA 483 Cosmetic Science Laboratories, LLC - Form 483, 2022-09-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more